GlobeNewswire (May 10, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 24, 2013)
-
-
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Mar 11, 2013)
-
-
GlobeNewswire (Feb 20, 2013)
-
-
GlobeNewswire (Feb 6, 2013)
-
GlobeNewswire (Jan 10, 2013)
-
GlobeNewswire (Jan 2, 2013)
-
-
-
Best Performing Russell 3000 Stocks YTDBespoke Investment Group • Thu, Nov 29, 2012
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
Sunesis: Publish or Perish?Derek Lowe • Fri, Sep 19, 2008
-
-
-
-
-
Best Performing Russell 3000 Stocks YTDBespoke Investment Group • Thu, Nov 29, 2012
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sunesis Pharmaceuticals Inc. Q4 2007 Earnings Call TranscriptTue, Mar 11, 2008
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 24, 2013)
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Mar 11, 2013)
-
GlobeNewswire (Feb 20, 2013)
-
GlobeNewswire (Feb 6, 2013)
-
GlobeNewswire (Jan 10, 2013)
-
GlobeNewswire (Jan 2, 2013)
-
GlobeNewswire (Nov 20, 2012)
-
GlobeNewswire (Nov 8, 2012)
-
GlobeNewswire (Nov 7, 2012)
-
GlobeNewswire (Nov 1, 2012)
-
GlobeNewswire (Oct 2, 2012)
-
GlobeNewswire (Sep 27, 2012)
-
GlobeNewswire (Sep 20, 2012)
-
at MarketWatch.com (Sep 13, 2012)
-
at MarketWatch.com (Sep 13, 2012)
SNSS vs. ETF Alternatives
Company Description
We are a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. We have built a highly experienced cancer drug development organization committed to advancing our lead product candidate,... More
